Randolph V Fugit
Title | Lecturer |
---|
Institution | University of Colorado Denver - Anschutz Medical Campus |
---|
Department | SOP-PROFESSIONAL PHARM EDUC |
---|
Phone | 303/724-3534 |
---|
|
|
|
Bibliographic
-
Greenwell K, Fugit R, Nicholson L, Wright J. A Retrospective Comparison of HIV Pre-exposure Prophylaxis (PrEP) Outcomes Between a Pharmacist-led Telehealth Clinic and In-person Clinic in a Veteran Population. AIDS Behav. 2023 Nov; 27(11):3678-3686. PMID: 37247044.
-
Fugit RV, McCoury JB, Bessesen MT. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program. Am J Health Syst Pharm. 2023 05 24; 80(Suppl 2):S49-S54. PMID: 36371732.
-
Bai X, Buckle AM, Vladar EK, Janoff EN, Khare R, Ordway D, Beckham D, Fornis LB, Majluf-Cruz A, Fugit RV, Freed BM, Kim S, Sandhaus RA, Chan ED. Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Sci Rep. 2022 Apr 19; 12(1):6466. PMID: 35440617.
-
Bai X, Buckle AM, Vladar EK, Janoff EN, Khare R, Ordway D, Beckham D, Fornis LB, Majluf-Cruz A, Fugit RV, Freed BM, Kim S, Sandhaus RA, Chan ED. Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Sci Rep. 2022 03 25; 12(1):5207. PMID: 35338216.
-
Hojat LS, Bessesen MT, Huang M, Reid M, Knepper BC, Miller MA, Shihadeh KC, Fugit RV, Jenkins TC. Effectiveness of Shorter Versus Longer Durations of Therapy for Common Inpatient Infections Associated With Bacteremia: A Multicenter, Propensity-Weighted Cohort Study. Clin Infect Dis. 2020 12 15; 71(12):3071-3078. PMID: 31858136.
-
Williams JG, Phan H, Winston HR, Fugit RV, Graney B, Jamroz B, English B, Chan ED. A 27-Year-Old Man With Acute Severe Low Back Pain and Bilateral Leg Swelling That Prompted Renting a Wheelchair for Mobility. Chest. 2017 Feb; 151(2):e35-e39. PMID: 28183502.
-
Bessesen MT, Ma A, Clegg D, Fugit RV, Pepe A, Goetz MB, Graber CJ. Antimicrobial Stewardship Programs: Comparison of a Program with Infectious Diseases Pharmacist Support to a Program with a Geographic Pharmacist Staffing Model. Hosp Pharm. 2015 Jun; 50(6):477-83. PMID: 26405339.
-
Pletz MW, Fugit RV, McGee L, Glasheen JJ, Keller DL, Welte T, Klugman KP. Fluoroquinolone-resistant Streptococcus pneumoniae. Emerg Infect Dis. 2006 Sep; 12(9):1462-3. PMID: 17073107.
-
Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005 Jul; 20(7):653-6. PMID: 16050864.
-
Cavendish JJ, Fugit RV, Safani M. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes. Curr Med Res Opin. 2004 Nov; 20(11):1839-43. PMID: 15537484.
-
Glasheen JJ, Fugit RV, Prochazka AV. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment. Pharmacotherapy. 2003 Aug; 23(8):1079-80; discussion 1080. PMID: 12921255.
-
Fugit RV, Resch ND. Conversion of patients from simvastatin to lovastatin in an outpatient pharmacy clinic. Am J Health Syst Pharm. 2000 Sep 15; 57(18):1703-8. PMID: 11006798.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2000 | 1 | 2003 | 1 | 2004 | 1 | 2005 | 1 | 2006 | 1 | 2015 | 1 | 2017 | 1 | 2020 | 1 | 2022 | 2 | 2023 | 2 |
To return to the timeline, click here.
|
Fugit's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|